Skip to content

Dossier · GDRZF · Dormant

GDRZF

Last analysed · · source: watchlist_research

Current thesis

Scheme-of-arrangement casualty. Gold Fields A$3.40 offer for ASX:GOR recommended 2025-05-05, targeted H2 2025 close. Absence of any 2026 news/filings/price signals the ticker is dead. Untradeable placeholder until ASX:GOR listing status is explicitly re-verified; base case is permanent watchlist removal.

Invalidation trigger

Any entry invalid by default: no price data in packet + no 2026 filings = presumed delisted. Operational invalidation if revived: ASX:GOR weekly close below A$3.00, or AUD gold weekly close below A$3,600/oz, or Gruyere AISC print >A$1,900/oz.

Thesis status

Open commitment catalyst duescored if the trigger above fires How this is scored →

Current Thesis

Scheme-of-arrangement casualty. Gold Fields (GFI) A$3.40+contingent offer for ASX:GOR, announced 2025-03-24 and recommended by the board 2025-05-05, was targeted for H2 2025 close. Base case is the scheme completed on schedule and GDRZF's OTC quote is either frozen at cash-equivalent consideration or outright dead. No news, no filings, no price in packet as of 2026-04-20 — consistent with a terminated listing, not a live ticker. Until ASX:GOR's "removal from official list" announcement is explicitly contradicted, this is an untradeable placeholder. Zero narrative velocity, zero options flow, zero setup. Archetype 7 only because "delisted" isn't a real bucket.

Bull Case

  • Only live bull case: scheme failed / renegotiated. Gold Fields 2025-03-24 initial offer A$2.27/sh cash + A$0.50 De Grey-scrip was rejected; 2025-05-05 revised A$3.40/sh cash recommended by board. If some late-2025 condition (FIRB, De Grey consideration mechanics, shareholder vote <75%) blew the deal, GOR re-emerges independent with AUD-gold tailwind intact.
  • Commodity backdrop: AUD gold printed ~A$4,100/oz into Q2 2026 vs ~A$3,400/oz when scheme was priced — a standalone Gold Road at A[entry redacted] cost basis would mechanically re-rate on >A[entry redacted]/oz Gruyere cash margin if the deal vaporized.
  • Optionality only: Yamarna belt (Gilmour, Smokebush) remained under-drilled at scheme time; standalone entity would monetise via resource upgrade into strength.

Bear Case

  • #1 risk: the ticker doesn't exist. No headlines, no filings, no price tape in the current packet is exactly the fingerprint of a security that stopped trading. Any "entry" here risks a zero-volume OTC print against a consideration escrow, not a real position.
  • If still alive, it's a rejected-suitor overhang name. Post-failed-M&A names historically trade dead for 6–12 months (cf. OZL 2022, Newcrest prior bids) — no narrative catalyst, no retail interest, no sell-side re-initiation.
  • Single-asset / single-jurisdiction. 50% Gruyere JV with Gold Fields as operator — any reconciliation, grade, or throughput miss is a 15–25% single-session drawdown with zero diversification buffer.
  • OTC liquidity trap. GDRZF prints are sporadic USD-converted copies of ASX:GOR. Slippage/spread destroys any modelled edge even if the underlying is live.

Setup & Price Structure

  • No price data in packet → no structure to analyse. This alone is disqualifying for our playbook. We don't enter names we can't chart.
  • Reference levels (historical, unverified live): ASX:GOR ranged A$1.60–A$2.10 pre-bid H1 2025; A$3.40 recommended-bid ceiling; USD equivalent at 0.66 AUDUSD ≈ $2.24 — any OTC print materially above or below that band is a scheme-outcome signal, not a trade.
  • No 20-EMA, no 50-EMA, no volume profile available. No stop can be specified. Cannot enter.

Catalyst Calendar (next 30 days)

  • 2026-04-28 to 2026-04-30 (est.): If ASX:GOR still listed, Q1 FY26 quarterly activities report is due on standard ASX cadence. Absence of this filing by 2026-04-30 is confirmation of delisting.
  • Pre-any-other-work (today, 2026-04-20): verify scheme completion via ASX announcements page for GOR — the April 19 research pass failed to resolve this and it remains the gating question.
  • No other scheduled catalysts. No earnings, no FDA, no index rebalance, no conference slot.

What Would Change Our Mind

  • Scheme CONFIRMED completed (ASX removal notice, or GFI 10-K mention) → drop from watchlist permanently. No tradeable security. This is the base case.
  • Scheme CONFIRMED failed AND Q1 FY26 print shows attributable production >40koz at AISC <A$1,900/oz AND ASX:GOR re-establishes a weekly higher-low above A$3.00 → re-seat as a live research candidate and benchmark vs NST/EVN/RRL/RMS/CMM peer group. Not before all three conditions.
  • AUD gold (XAU × AUDUSD) weekly close below A$3,600/oz → entire Aussie gold complex thesis breaks; GDRZF de-prioritised regardless of corporate action.

Correlation Notes

  • Direct corporate link: Gold Fields (NYSE:GFI / JSE:GFI) — the acquirer. GFI's own disclosures are the cleanest source for scheme completion confirmation.
  • ASX gold peer basket: NST (Northern Star), EVN (Evolution), RRL (Regis), RMS (Ramelius), CMM (Capricorn Metals), GMD (Genesis Minerals). Do not stack if/when GDRZF returns.
  • Macro drivers: AUD gold (XAU × AUD/USD), US real yields (TIP), DXY, SPDR GLD flows.
  • Theme cohort: 2023–2025 Aussie gold consolidation cycle (Newmont/Newcrest 2023, Northern Star/De Grey 2024, Gold Fields/Gold Road 2025). The M&A cycle itself may now be late-stage / saturated.

Pipeline notes

  • "2026-04-18: seed: Serenity/attention list", "Base case as of 2026-04-20: Gold Fields scheme completed H2 2025, GDRZF OTC quote frozen or delisted. No tradeable security.", "Gating action: verify ASX:GOR removal notice before any further research cycles are spent on this name.", If Q1 FY26 quarterly activities report does NOT print by 2026-04-30, treat as confirmation of delisting and remove from watchlist., Do not enter any order while 'no price context' persists in the packet — zero-volume OTC prints against escrow consideration are a trap, not a trade., If scheme failed and name returns, benchmark vs NST/EVN/RRL/RMS/CMM before sizing; rejected-suitor overhang historically caps upside 6–12 months.